FDA tightens rules for cough, cold, or allergy related medicines

FDA alleged in letters to drug companies that their products were ‘unapproved new drugs’ which can no longer be marketed legally in the US for safety problems associated with the drugs.

Previosly, FDA has taken initiative against the drugs which contain highly addictive narcotic active ingredients as a part of its ‘unapproved drugs initiative,’ which was introduced in June 2006.

FDAImports.com founder Benjamin England said this recent action is the first taken against such a minimally-dangerous drug category – allergy drugs.

"These cough, cold and allergy prescription drugs failed the FDA test on efficacy, so they are out and so they are no longer available to licensed physicians," England said.